Government & Regulation

Four groups are condemning CMS’ proposed 2027 Hospital Outpatient Prospective Payment System and Ambulatory Surgery Center rule, which would cut what Medicare pays hospitals for 340B drugs and expand site-neutral payments into a new category of services. The rule, issued…

California’s new nurse-to-patient staffing ratios at acute, freestanding psychiatric hospitals took effect June 1, and in the early days of implementation, 65 beds — roughly half of them youth beds — across four counties were closing in the state. Facilities struggled to…

The FDA is issuing national priority vouchers to three companies studying psychedelic drugs to treat serious mental illness.  The vouchers were issued to companies studying psilocybin for treatment-resistant depression and major depressive disorder as well as methylone for post-traumatic stress disorder, following President Donald…

The Justice Department and Drug Enforcement Administration have placed FDA-approved products containing marijuana and state-licensed medical marijuana products in Schedule III of the Controlled Substances Act.  The order takes effect immediately and also initiates an expedited administrative hearing process to evaluate broader…

President Donald Trump signed an executive order Jan. 29 establishing the Great American Recovery Initiative, a coordinated federal effort to address addiction in the U.S.  The initiative aims to streamline government programs, integrate evidence-based care and improve access to treatment…